Terry Dagnon

Chief Operating Officer, Outlook Therapeutics, Inc.

Companies

Outlook Therapeutics, Inc.Chief Operations Officer Apr 19, 2023 to Apr 21, 2023¹
Outlook Therapeutics, Inc.Chief operating officer Dec 4, 2018 to Jun 23, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Outlook Therapeutics, Inc. OTLK653,058 shares³$326.5K at $0.50Apr 20, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Apr 20, 2023Sold 520,000 shares at $1.14 of Outlook Therapeutics, Inc.³
Jun 21, 2022Bought 10,000 shares at $1.05 of Outlook Therapeutics, Inc.⁴
Dec 6, 2021Bought 25,201 shares at $1.38 of Outlook Therapeutics, Inc.⁵
Dec 3, 2021Bought 10,000 shares at $1.42 of Outlook Therapeutics, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROutlook Therapeutics, Inc., Chief Operations Officer
2
SEC EDGAROutlook Therapeutics, Inc., Chief operating officer
3
SEC EDGAROutlook Therapeutics, Inc. shares after the filing of Apr 20, 2023
4
SEC EDGARForm 4 filed Jun 23, 2022
5
SEC EDGARForm 4 filed Dec 6, 2021
6
SEC EDGARForm 4 filed Dec 3, 2021